YTHDF1 and urinary bladder cancer: Similar to the IGF2BPs family, YTHDF1/2/3 promote bladder cancer progression and suppress tumor immunity (Zhang et al., 2023[343]; Jin et al., 2019[112]; Qiu et al., 2024[196]).